RECENT FUNDING ROUNDS
Company | Country | Profile | Funding round | Value | Date | |
---|---|---|---|---|---|---|
Blossomhill Therapeutics Inc | Biotechnology company focused on oncology and autoimmune disorders. | Series A | USD 71,000,000 |
MOST ACTIVE INVESTORS
Cormorant Asset Management | 1 | |
Hercules BioVentures | 1 | |
OrbiMed Advisors LLC | US | 1 |
Vivo Capital | 1 |
BEST FUNDED
Biotechnology company focused on oncology and autoimmune disorders.